The coronary microcirculation (CM) plays a critical role in the regulation of blood flow and nutrient exchange to support the viability of the heart. In many disease states, the CM becomes structurally and functionally impaired, and transthoracic Doppler echocardiography can be used as a non-invasive surrogate to assess CM disease. Analysis of Doppler echocardiography is prone to user bias and can be laborious, especially if additional parameters are collected. We hypothesized that we could develop a MATLAB algorithm to automatically analyze clinically-relevant and non-traditional parameters from murine PW Doppler coronary flow patterns that would reduce intra- and inter-operator bias, and analysis time. Our results show a significant reduction in intra- and inter-observer variability as well as a 30 fold decrease in analysis time with the automated program vs. manual analysis. Finally, we demonstrated good agreement between automated and manual analysis for clinically-relevant parameters under baseline and hyperemic conditions. Resulting coronary flow velocity reserve calculations were also found to be in good agreement. We present a MATLAB algorithm that is user friendly and robust in defining and measuring Doppler coronary flow pattern parameters for more efficient and potentially more insightful analysis assessed via Doppler echocardiography.
IntroductionType 2 diabetic (T2DM) coronary resistance microvessels (CRMs) show early inward hypertrophic remodeling and reduced wall stiffness, which are associated with decreased blood flow (CBF), coronary flow reserve, and disrupted flow patterns. These data may suggest that coronary microvascular disease (CMD) underlies the early pathophysiology of T2DM. Furthermore, distinct correlations have been identified between the Doppler coronary flow pattern in both normal and T2DM mice, potentially allowing for a predictive relationship between coronary flow patterns and CMD. Currently, CMD is extremely difficult to diagnose due to lack of non‐invasive methods. The goal of this study was to develop an applied predictive model for CMD non‐invasively in early T2DM using CBF combined with functional and structural measurements of the heart.MethodsCBF of the left main coronary artery, aortic flow, E & A wave, left ventricular structural dimensions, and aortic diameter were recorded using high frequency, high resolution non‐invasive Doppler echocardiography (Vevo2100, Visual Sonics, Toronto, Canada) in 37 normal heterozygous Db/db mice and 36 T2DM homozygous db/db mice. Coronary flow patterns were analyzed using a Matlab program developed in our laboratory to identify 13 distinct parameters. All other flow patterns and structural and functional features were manually measured in the Vevo2100 software resulting in 13 additional parameters. All the parameters were feature engineered, and a factor analysis model was created and tested using various machine learning algorithms.ResultsPhysiological data were subjected to a variety of machine learning models, and the “glmnet algorithm” in R software (generalized linear regression via penalized maximum likelihood) best predicted CMD with a cross validation accuracy of 80.19% and test dataset accuracy to date of 84.84%.ConclusionAn applied predictive model for CMD in T2DM was developed using 73 mice, which shows a promising ability to accurately predict CMD in T2DM. Further studies will be undertaken to improve the predictive accuracy of the model to be suitable for clinical diagnostics and/or decision support.Support or Funding InformationSupported by the National Institutes of Health (R00 HL‐116769 to AJT) and Nationwide Children's Hospital (to AJT and CWB).This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.